Teleflex Launches ARROW ® JACC (Jugular Axillo-subclavian Central Catheter) with Chlorag + ard ® Technology, the First and Only Long-Term Antimicrobial and Antithrombogenic CVC The ARROW ® JACC is ...

LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) , a leading global provider of medical devices for critical care and surgery, has announced the first insertion of the new ARROW ® ...

A major difference between children and adults is that in pediatric patients, age and, particularly, weight and length of the patient are decisive factors determining the choice of CVC type and ...

LIMERICK, Pa--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will feature two new ARROW ® Vascular Access innovations ...

The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the role of ...

The use of antimicrobial-impregnated catheters should be considered in all circumstances, especially when the institutional rate of catheter-related bloodstream infections is higher than 2 percent, ...

Teleflex ($TFX) picked up European approval to market its GPSCath device, designed to prop open vessels and reduce procedure times for vascular interventions. The ...

The recent product launch by Teleflex Incorporated (TFX) should further boost the positive trend displayed by TFX’s stock price over the last week. Moreover, 1 out of 6 estimates for 2014 moved up in ...

Teleflex Announces First Insertion of ARROW ® JACC™ Catheterwith Chlorag + ard ® Technology LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) , a leading global provider of medical ...